Literature DB >> 9922352

Sustained high pressure double balloon angioplasty of calcified conduits.

N Sreeram1, P Hutter, E Silove.   

Abstract

OBJECTIVE: To assess the efficacy of prolonged high pressure angioplasty for dilatation of calcified and stenotic cardiac conduits in children.
DESIGN: A prospective study of consecutive patients presenting with calcified and stenotic conduits.
SETTING: Two tertiary paediatric cardiology departments.
METHODS: Sustained (up to five minutes), high pressure (up to 18 atmospheres), double balloon angioplasty was performed in six calcified and stenotic cardiac conduits (five consecutive patients, three male, two female, age 4 to 17 years). Four patients had right ventricle to pulmonary artery (RV-PA) conduits, and one had two venous conduits in a Fontan circulation.
RESULTS: Marked reductions in right ventricle to pulmonary artery gradients, from a median (range) of 48 (40 to 62) mm Hg to 11 (5 to 16) mm Hg, and in right ventricle to femoral artery pressure ratios, from a median of 0.8 (0.72 to 0.86) to 0.4 (0.33 to 0.44), were achieved for all RV-PA conduits. All five patients had sustained clinical improvement at follow up (median follow up 12 months) and none has required reintervention or surgery.
CONCLUSIONS: Prolonged high pressure double balloon angioplasty may have a role in prolonging the interval between conduit replacements in a subset of patients with complex heart defects.

Entities:  

Mesh:

Year:  1999        PMID: 9922352      PMCID: PMC1728930          DOI: 10.1136/hrt.81.2.162

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  7 in total

1.  Balloon dilatation of porcine bioprosthetic valves in the pulmonary position.

Authors:  J D Waldman; F J Schoen; S E Kirkpatrick; J W Mathewson; L George; J J Lamberti
Journal:  Circulation       Date:  1987-07       Impact factor: 29.690

2.  Balloon selection for double balloon valvotomy.

Authors:  S B Yeager
Journal:  J Am Coll Cardiol       Date:  1987-02       Impact factor: 24.094

3.  Intravascular stent prosthesis for right ventricular outflow obstruction.

Authors:  M C Hosking; L N Benson; T Nakanishi; P E Burrows; W G Williams; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1992-08       Impact factor: 24.094

4.  Implantation and intermediate-term follow-up of stents in congenital heart disease.

Authors:  M P O'Laughlin; M C Slack; R G Grifka; S B Perry; J E Lock; C E Mullins
Journal:  Circulation       Date:  1993-08       Impact factor: 29.690

5.  Prolongation of RV-PA conduit life span by percutaneous stent implantation. Intermediate-term results.

Authors:  A J Powell; J E Lock; J F Keane; S B Perry
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

6.  Balloon dilation valvuloplasty of bioprosthetic valves in extracardiac conduits.

Authors:  T R Lloyd; W J Marvin; L T Mahoney; R M Lauer
Journal:  Am Heart J       Date:  1987-08       Impact factor: 4.749

7.  Double balloon technique for dilation of valvular or vessel stenosis in congenital and acquired heart disease.

Authors:  C E Mullins; M R Nihill; G W Vick; A Ludomirsky; M P O'Laughlin; J T Bricker; V E Judd
Journal:  J Am Coll Cardiol       Date:  1987-07       Impact factor: 24.094

  7 in total
  3 in total

1.  Implantation of endovascular stents for the obstructive right ventricular outflow tract.

Authors:  H Sugiyama; W Williams; L N Benson
Journal:  Heart       Date:  2005-08       Impact factor: 5.994

2.  Percutaneous balloon dilation of Carpentier-Edwards porcine-valved right ventricle-to-pulmonary artery conduits.

Authors:  Amanda C Hall; Daniel E Miga; Glenn T Leonard; Hongyue Wang; Rae-Ellen Kavey; George M Alfieris
Journal:  Pediatr Cardiol       Date:  2012-12-11       Impact factor: 1.655

3.  How Long Can the Next Intervention Be Delayed after Balloon Dilatation of Homograft in the Pulmonary Position?

Authors:  Hye-In Jeong; Jinyoung Song; Eun Young Choi; Sung Ho Kim; Jun Huh; I-Seok Kang; Ji Hyuk Yang; Tae Gook Jun
Journal:  Korean Circ J       Date:  2017-09-11       Impact factor: 3.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.